Tag: Obesity
RSNA: Obesity, VAT Linked to Measures of Amyloid Burden in Midlife
Visceral adipose tissue had significant direct effect on amyloid burden, which was not explained by HOMA-IR
Cardiovascular Risk and Obesity Affect Brain Volume in Middle Age
Strongest influence seen between 55 and 64 years in men and between 65 and 74 years in women
Antiobesity Medications Tied to Decreased Alcohol Use
Findings seen among individuals enrolled in a telehealth weight management program
Younger Age at Diabetes Diagnosis Tied to Higher Risk for Later Dementia
Risk tripled for individuals diagnosed at younger than 50 years who are living with obesity
U.S. Overweight, Obesity Rates Set to Continue Increasing to 2050
Total number of children and adolescents with overweight and obesity expected to reach 43.1 million by 2050
Vitamin D Supplements May Lower Blood Pressure in Seniors With Overweight
Reduction seen in overall cohort and in those with BMI >30, hypertension
Tirzepatide Yields Sustained Weight Reduction in Obesity, Prediabetes
Three years of tirzepatide also reduced risk for progression to type 2 diabetes compared with placebo
Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
Impact of expanding access to GLP-1 receptor agonists, dual gastric inhibitory polypeptide and GLP-1 receptor agonists quantified
Semaglutide Beneficial for People With Obesity, Knee Osteoarthritis
Semaglutide results in greater reductions in body weight and pain related to knee osteoarthritis than placebo
Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries
Authors say clinicians should evaluate trade-offs between pharmaceutical and surgical management of obesity
